Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Apraglutide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ironwood Pharmaceuticals Reports Fourth Quarter 2025 Result
    Ironwood Pharmaceuticals Reports Fourth Quarter 2025 Result

    25 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-25/ironwood-pharmaceuticals-reports-fourth-quarter-and-full-year-2025-results-achieves-2025-financial

    PHARMIWEB
    25 Feb 2026
    Share Share
    Ironwood Pharmaceuticals Updates on Apraglutide Clinical Trials
    Ironwood Pharmaceuticals Updates on Apraglutide Clinical Trials

    14 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250414687154/en/Ironwood-Pharmaceuticals-Provides-Clinical-and-Regulatory-Update-on-Apraglutide

    BUSINESSWIRE
    14 Apr 2025
    Share Share
    Ironwood Submits Apraglutide NDA, Updates Corporate Structure
    Ironwood Submits Apraglutide NDA, Updates Corporate Structure

    29 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250129150325/en

    BUSINESSWIRE
    29 Jan 2025
    Share Share
    Ironwood makes bid for $1B GI drug with subgroup data
    Ironwood makes bid for $1B GI drug with subgroup data

    29 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ramping-fda-submission-ironwood-makes-further-bid-1b-gi-drug-subgroup-data

    FIERCE BIOTECH
    29 Oct 2024
    Share Share
    Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker
    Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521515089/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    Ironwood: Apraglutide SBS-IF Data At DDW 2024
    Ironwood: Apraglutide SBS-IF Data At DDW 2024

    01 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240501757166/en

    BUSINESSWIRE
    01 May 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.